Viokace
NDC 73562-104, Pancrelipase, tablet, from Aimmune Therapeutics, Inc..
- Product NDC
- 73562-104
- Status
- Listed
- Labeler
- Aimmune Therapeutics, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA022542
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73562-104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PANCRELIPASE LIPASE10440 [USP'U]/1
- PANCRELIPASE PROTEASE39150 [USP'U]/1
- PANCRELIPASE AMYLASE39150 [USP'U]/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73562-104-10 | 73562010410 | 1 BOTTLE in 1 CARTON (73562-104-10) / 100 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/58bdb8de-582d-44e6-9b72-8d5a42fdf501NADAC price for package 73562010410
GET /v1/drugs/nadac/73562010410
Use it
Look up 73562-104 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73562-104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73562-104. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.